Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023

Loading...
Loading...

Upgrades

According to Sidoti & Co., the prior rating for Federal Agricultural Mortgage Corp AGM was changed from Neutral to Buy. In the fourth quarter, Federal Agricultural showed an EPS of $3.16, compared to $2.76 from the year-ago quarter. The current stock performance of Federal Agricultural shows a 52-week-high of $149.37 and a 52-week-low of $90.44. Moreover, at the end of the last trading period, the closing price was at $126.74.

According to Credit Suisse, the prior rating for Enbridge Inc ENB was changed from Underperform to Neutral. Enbridge earned $0.47 in the fourth quarter, compared to $0.54 in the year-ago quarter. At the moment, the stock has a 52-week-high of $47.67 and a 52-week-low of $35.04. Enbridge closed at $36.73 at the end of the last trading period.

B of A Securities upgraded the previous rating for NEXTracker Inc NXT from Neutral to Buy. The current stock performance of NEXTracker shows a 52-week-high of $35.10 and a 52-week-low of $28.24. Moreover, at the end of the last trading period, the closing price was at $32.52.

Susquehanna upgraded the previous rating for Carnival Corp CCL from Neutral to Positive. In the first quarter, Carnival showed an EPS of $0.55, compared to $1.66 from the year-ago quarter. The stock has a 52-week-high of $21.49 and a 52-week-low of $6.12. At the end of the last trading period, Carnival closed at $9.33.

According to Citigroup, the prior rating for Lululemon Athletica Inc LULU was changed from Neutral to Buy. For the fourth quarter, Lululemon Athletica had an EPS of $4.40, compared to year-ago quarter EPS of $3.37. The current stock performance of Lululemon Athletica shows a 52-week-high of $410.70 and a 52-week-low of $252.01. Moreover, at the end of the last trading period, the closing price was at $320.31.

Credit Suisse upgraded the previous rating for Invesco Ltd IVZ from Underperform to Neutral. For the fourth quarter, Invesco had an EPS of $0.39, compared to year-ago quarter EPS of $0.86. At the moment, the stock has a 52-week-high of $23.83 and a 52-week-low of $13.20. Invesco closed at $15.62 at the end of the last trading period.

Goldman Sachs upgraded the previous rating for Marathon Petroleum Corp MPC from Neutral to Buy. In the fourth quarter, Marathon Petroleum showed an EPS of $6.65, compared to $1.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $136.46 and a 52-week-low of $77.62. Marathon Petroleum closed at $131.57 at the end of the last trading period.

Goldman Sachs upgraded the previous rating for The Hartford Financial Services Group Inc HIG from Neutral to Buy. For the fourth quarter, Hartford Finl Servs Gr had an EPS of $2.31, compared to year-ago quarter EPS of $2.02. At the moment, the stock has a 52-week-high of $79.44 and a 52-week-low of $60.19. Hartford Finl Servs Gr closed at $67.00 at the end of the last trading period.

For The Hershey Co HSY, Wells Fargo upgraded the previous rating of Underweight to Equal-Weight. Hershey earned $2.02 in the fourth quarter, compared to $1.69 in the year-ago quarter. At the moment, the stock has a 52-week-high of $253.97 and a 52-week-low of $201.66. Hershey closed at $252.90 at the end of the last trading period.

Exane BNP Paribas upgraded the previous rating for Omnicom Group Inc OMC from Underperform to Neutral. For the fourth quarter, Omnicom Group had an EPS of $2.09, compared to year-ago quarter EPS of $1.95. The stock has a 52-week-high of $96.52 and a 52-week-low of $61.38. At the end of the last trading period, Omnicom Group closed at $88.73.

UBS upgraded the previous rating for ArcelorMittal SA MT from Sell to Buy. In the fourth quarter, ArcelorMittal showed an EPS of $0.30, compared to $3.70 from the year-ago quarter. The current stock performance of ArcelorMittal shows a 52-week-high of $33.90 and a 52-week-low of $19.25. Moreover, at the end of the last trading period, the closing price was at $28.90.

According to CFRA, the prior rating for Charter Communications Inc CHTR was changed from Underweight to Market Weight. In the fourth quarter, Charter Communications showed an EPS of $7.69, compared to $8.93 from the year-ago quarter. The current stock performance of Charter Communications shows a 52-week-high of $574.65 and a 52-week-low of $297.83. Moreover, at the end of the last trading period, the closing price was at $345.54.

See all analyst ratings upgrades.

Downgrades

Gordon Haskett downgraded the previous rating for Macy's Inc M from Accumulate to Hold. In the fourth quarter, Macy's showed an EPS of $1.88, compared to $2.45 from the year-ago quarter. The stock has a 52-week-high of $27.28 and a 52-week-low of $15.11. At the end of the last trading period, Macy's closed at $17.27.

For Vermilion Energy Inc VET, TD Cowen downgraded the previous rating of Buy to Hold. Vermilion Energy earned $1.80 in the fourth quarter, compared to $1.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $30.16 and a 52-week-low of $11.93. Vermilion Energy closed at $12.75 at the end of the last trading period.

Maxim Group downgraded the previous rating for Generation Income Properties Inc GIPR from Buy to Hold. The stock has a 52-week-high of $7.75 and a 52-week-low of $4.66. At the end of the last trading period, Generation Income closed at $4.90.

For Monopar Therapeutics Inc MNPR, Maxim Group downgraded the previous rating of Buy to Hold. For the fourth quarter, Monopar Therapeutics had an EPS of $0.22, compared to year-ago quarter EPS of $0.21. The stock has a 52-week-high of $4.88 and a 52-week-low of $1.35. At the end of the last trading period, Monopar Therapeutics closed at $1.45.

For Vermilion Energy Inc VET, TD Securities downgraded the previous rating of Buy to Hold. In the fourth quarter, Vermilion Energy showed an EPS of $1.80, compared to $1.68 from the year-ago quarter. The stock has a 52-week-high of $30.16 and a 52-week-low of $11.93. At the end of the last trading period, Vermilion Energy closed at $12.75.

According to UBS, the prior rating for Foot Locker Inc FL was changed from Neutral to Sell. For the fourth quarter, Foot Locker had an EPS of $0.97, compared to year-ago quarter EPS of $1.67. The current stock performance of Foot Locker shows a 52-week-high of $47.22 and a 52-week-low of $23.86. Moreover, at the end of the last trading period, the closing price was at $40.03.

UBS downgraded the previous rating for Urban Outfitters Inc URBN from Neutral to Sell. For the fourth quarter, Urban Outfitters had an EPS of $0.34, compared to year-ago quarter EPS of $0.41. At the moment, the stock has a 52-week-high of $29.74 and a 52-week-low of $17.84. Urban Outfitters closed at $26.76 at the end of the last trading period.

For Burlington Stores Inc BURL, UBS downgraded the previous rating of Neutral to Sell. Burlington Stores earned $2.96 in the fourth quarter, compared to $2.53 in the year-ago quarter. The stock has a 52-week-high of $239.94 and a 52-week-low of $106.81. At the end of the last trading period, Burlington Stores closed at $201.27.

For Ross Stores Inc ROST, UBS downgraded the previous rating of Neutral to Sell. Ross Stores earned $1.31 in the fourth quarter, compared to $1.05 in the year-ago quarter. At the moment, the stock has a 52-week-high of $122.44 and a 52-week-low of $69.24. Ross Stores closed at $103.14 at the end of the last trading period.

For Bath & Body Works Inc BBWI, UBS downgraded the previous rating of Buy to Neutral. Bath & Body Works earned $1.86 in the fourth quarter, compared to $2.30 in the year-ago quarter. The current stock performance of Bath & Body Works shows a 52-week-high of $57.90 and a 52-week-low of $25.81. Moreover, at the end of the last trading period, the closing price was at $38.04.

According to Needham, the prior rating for Penumbra Inc PEN was changed from Buy to Hold. Penumbra earned $0.16 in the fourth quarter, compared to $0.10 in the year-ago quarter. The current stock performance of Penumbra shows a 52-week-high of $283.42 and a 52-week-low of $115.08. Moreover, at the end of the last trading period, the closing price was at $275.54.

Exane BNP Paribas downgraded the previous rating for The Interpublic Group of Companies Inc IPG from Outperform to Neutral. For the fourth quarter, Interpublic Gr of Cos had an EPS of $1.02, compared to year-ago quarter EPS of $0.82. At the moment, the stock has a 52-week-high of $39.52 and a 52-week-low of $25.14. Interpublic Gr of Cos closed at $35.24 at the end of the last trading period.

For Delek US Holdings Inc DK, Goldman Sachs downgraded the previous rating of Buy to Neutral. For the fourth quarter, Delek US Hldgs had an EPS of $0.88, compared to year-ago quarter EPS of $0.61. The current stock performance of Delek US Hldgs shows a 52-week-high of $35.23 and a 52-week-low of $19.27. Moreover, at the end of the last trading period, the closing price was at $23.49.

For Ciena Corp CIEN, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Ciena earned $0.64 in the first quarter, compared to $0.47 in the year-ago quarter. At the moment, the stock has a 52-week-high of $61.97 and a 52-week-low of $38.35. Ciena closed at $50.87 at the end of the last trading period.

See all analyst ratings downgrades.

Initiations

With a Buy rating, UBS initiated coverage on InMode Ltd INMD. The price target seems to have been set at $40.00 for InMode. For the fourth quarter, InMode had an EPS of $0.78, compared to year-ago quarter EPS of $0.64. The stock has a 52-week-high of $41.84 and a 52-week-low of $20.60. At the end of the last trading period, InMode closed at $30.00.

Craig-Hallum initiated coverage on Gambling.com Group Ltd GAMB with a Buy rating. The price target for Gambling.com Gr is set to $15.00. For the fourth quarter, Gambling.com Gr had an EPS of $0.02, compared to year-ago quarter EPS of $0.02. The current stock performance of Gambling.com Gr shows a 52-week-high of $10.50 and a 52-week-low of $6.62. Moreover, at the end of the last trading period, the closing price was at $9.57.

EF Hutton initiated coverage on IN8bio Inc INAB with a Buy rating. The price target for IN8bio is set to $8.00. IN8bio earned $0.34 in the third quarter, compared to $0.25 in the year-ago quarter. At the moment, the stock has a 52-week-high of $4.88 and a 52-week-low of $1.12. IN8bio closed at $1.23 at the end of the last trading period.

Loading...
Loading...

Wells Fargo initiated coverage on AvalonBay Communities Inc AVB with an Overweight rating. The price target for AvalonBay Communities is set to $184.00. AvalonBay Communities earned $2.59 in the fourth quarter, compared to $2.27 in the year-ago quarter. The stock has a 52-week-high of $258.92 and a 52-week-low of $153.07. At the end of the last trading period, AvalonBay Communities closed at $157.32.

With an Underweight rating, Wells Fargo initiated coverage on Camden Property Trust CPT. The price target seems to have been set at $102.00 for Camden Prop Trust. In the fourth quarter, Camden Prop Trust showed an EPS of $1.74, compared to $1.51 from the year-ago quarter. The stock has a 52-week-high of $175.69 and a 52-week-low of $97.74. At the end of the last trading period, Camden Prop Trust closed at $100.51.

With a Equal-Weight rating, Wells Fargo initiated coverage on Equity Residential EQR. The price target seems to have been set at $62.00 for Equity Residential. For the fourth quarter, Equity Residential had an EPS of $0.94, compared to year-ago quarter EPS of $0.82. At the moment, the stock has a 52-week-high of $94.31 and a 52-week-low of $54.60. Equity Residential closed at $55.92 at the end of the last trading period.

With an Underweight rating, Wells Fargo initiated coverage on Essex Property Trust Inc ESS. The price target seems to have been set at $208.00 for Essex Property Trust. For the fourth quarter, Essex Property Trust had an EPS of $3.77, compared to year-ago quarter EPS of $3.25. At the moment, the stock has a 52-week-high of $363.00 and a 52-week-low of $195.03. Essex Property Trust closed at $200.26 at the end of the last trading period.

Wells Fargo initiated coverage on UDR Inc UDR with an Overweight rating. The price target for UDR is set to $44.50. In the fourth quarter, UDR showed an EPS of $0.61, compared to $0.54 from the year-ago quarter. The stock has a 52-week-high of $60.01 and a 52-week-low of $37.18. At the end of the last trading period, UDR closed at $38.37.

With a Equal-Weight rating, Wells Fargo initiated coverage on American Homes 4 Rent AMH. The price target seems to have been set at $31.00 for American Homes 4 Rent. In the fourth quarter, American Homes 4 Rent showed an EPS of $0.40, compared to $0.37 from the year-ago quarter. The current stock performance of American Homes 4 Rent shows a 52-week-high of $43.88 and a 52-week-low of $28.79. Moreover, at the end of the last trading period, the closing price was at $29.80.

With an Overweight rating, Wells Fargo initiated coverage on Equity Lifestyle Properties Inc ELS. The price target seems to have been set at $75.50 for Equity Lifestyle Props. Equity Lifestyle Props earned $0.66 in the fourth quarter, compared to $0.64 in the year-ago quarter. The stock has a 52-week-high of $83.77 and a 52-week-low of $57.01. At the end of the last trading period, Equity Lifestyle Props closed at $63.91.

Wells Fargo initiated coverage on Sun Communities Inc SUI with a Equal-Weight rating. The price target for Sun Communities is set to $151.00. In the fourth quarter, Sun Communities showed an EPS of $1.33, compared to $1.31 from the year-ago quarter. At the moment, the stock has a 52-week-high of $192.87 and a 52-week-low of $117.76. Sun Communities closed at $133.42 at the end of the last trading period.

HC Wainwright & Co. initiated coverage on Legend Biotech Corp LEGN with a Buy rating. The price target for Legend Biotech is set to $66.00. Legend Biotech earned $0.24 in the first quarter, compared to $0.30 in the year-ago quarter. The stock has a 52-week-high of $57.72 and a 52-week-low of $33.05. At the end of the last trading period, Legend Biotech closed at $46.81.

Jefferies initiated coverage on Enliven Therapeutics Inc ELVN with a Buy rating. The price target for Enliven Therapeutics is set to $27.00. At the moment, the stock has a 52-week-high of $25.34 and a 52-week-low of $19.24. Enliven Therapeutics closed at $23.49 at the end of the last trading period.

With a Neutral rating, Piper Sandler initiated coverage on SEI Investments Co SEIC. The price target seems to have been set at $60.00 for SEI Inv. For the fourth quarter, SEI Inv had an EPS of $0.83, compared to year-ago quarter EPS of $1.03. The stock has a 52-week-high of $64.69 and a 52-week-low of $46.30. At the end of the last trading period, SEI Inv closed at $55.83.

UBS initiated coverage on DexCom Inc DXCM with a Buy rating. The price target for DexCom is set to $142.00. For the fourth quarter, DexCom had an EPS of $0.34, compared to year-ago quarter EPS of $0.17. At the moment, the stock has a 52-week-high of $134.50 and a 52-week-low of $66.94. DexCom closed at $113.81 at the end of the last trading period.

With a Buy rating, UBS initiated coverage on Inspire Medical Systems Inc INSP. The price target seems to have been set at $300.00 for Inspire Medical Systems. For the fourth quarter, Inspire Medical Systems had an EPS of $0.10, compared to year-ago quarter EPS of $0.09. The current stock performance of Inspire Medical Systems shows a 52-week-high of $282.31 and a 52-week-low of $142.75. Moreover, at the end of the last trading period, the closing price was at $238.62.

With a Buy rating, UBS initiated coverage on Boston Scientific Corp BSX. The price target seems to have been set at $57.00 for Boston Scientific. For the fourth quarter, Boston Scientific had an EPS of $0.45, compared to year-ago quarter EPS of $0.45. At the moment, the stock has a 52-week-high of $49.22 and a 52-week-low of $34.98. Boston Scientific closed at $48.60 at the end of the last trading period.

UBS initiated coverage on Butterfly Network Inc BFLY with a Neutral rating. The price target for Butterfly Network is set to $2.25. In the fourth quarter, Butterfly Network showed an EPS of $0.17, compared to $0.08 from the year-ago quarter. At the moment, the stock has a 52-week-high of $8.72 and a 52-week-low of $1.76. Butterfly Network closed at $1.77 at the end of the last trading period.

UBS initiated coverage on Baxter International Inc BAX with a Neutral rating. The price target for Baxter Intl is set to $43.00. Baxter Intl earned $0.88 in the fourth quarter, compared to $1.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $80.71 and a 52-week-low of $37.34. Baxter Intl closed at $39.85 at the end of the last trading period.

With a Neutral rating, UBS initiated coverage on Intuitive Surgical Inc ISRG. The price target seems to have been set at $278.00 for Intuitive Surgical. In the fourth quarter, Intuitive Surgical showed an EPS of $1.23, compared to $1.30 from the year-ago quarter. The current stock performance of Intuitive Surgical shows a 52-week-high of $308.21 and a 52-week-low of $180.34. Moreover, at the end of the last trading period, the closing price was at $249.49.

UBS initiated coverage on Johnson & Johnson JNJ with a Neutral rating. The price target for Johnson & Johnson is set to $164.00. Johnson & Johnson earned $2.35 in the fourth quarter, compared to $2.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $186.68 and a 52-week-low of $150.11. Johnson & Johnson closed at $151.82 at the end of the last trading period.

With a Neutral rating, UBS initiated coverage on Tandem Diabetes Care Inc TNDM. The price target seems to have been set at $45.00 for Tandem Diabetes Care. For the fourth quarter, Tandem Diabetes Care had an EPS of $0.01, compared to year-ago quarter EPS of $0.16. At the moment, the stock has a 52-week-high of $123.96 and a 52-week-low of $33.52. Tandem Diabetes Care closed at $40.24 at the end of the last trading period.

With a Neutral rating, UBS initiated coverage on Edwards Lifesciences Corp EW. The price target seems to have been set at $84.00 for Edwards Lifesciences. For the fourth quarter, Edwards Lifesciences had an EPS of $0.64, compared to year-ago quarter EPS of $0.51. The current stock performance of Edwards Lifesciences shows a 52-week-high of $131.09 and a 52-week-low of $67.13. Moreover, at the end of the last trading period, the closing price was at $80.49.

UBS initiated coverage on Stryker Corp SYK with a Neutral rating. The price target for Stryker is set to $287.00. Stryker earned $3.00 in the fourth quarter, compared to $2.71 in the year-ago quarter. The stock has a 52-week-high of $284.00 and a 52-week-low of $188.92. At the end of the last trading period, Stryker closed at $277.41.

UBS initiated coverage on Zimmer Biomet Holdings Inc ZBH with a Sell rating. The price target for Zimmer Biomet Holdings is set to $112.00. Zimmer Biomet Holdings earned $1.88 in the fourth quarter, compared to $1.95 in the year-ago quarter. At the moment, the stock has a 52-week-high of $135.00 and a 52-week-low of $100.41. Zimmer Biomet Holdings closed at $126.14 at the end of the last trading period.

Wells Fargo initiated coverage on Invitation Homes Inc INVH with an Overweight rating. The price target for Invitation Homes is set to $33.50. For the fourth quarter, Invitation Homes had an EPS of $0.43, compared to year-ago quarter EPS of $0.39. The stock has a 52-week-high of $44.35 and a 52-week-low of $28.52. At the end of the last trading period, Invitation Homes closed at $29.46.

Mizuho initiated coverage on GitLab Inc GTLB with a Neutral rating. The price target for GitLab is set to $38.00. In the fourth quarter, GitLab showed an EPS of $0.03, compared to $0.16 from the year-ago quarter. The stock has a 52-week-high of $70.91 and a 52-week-low of $30.92. At the end of the last trading period, GitLab closed at $33.90.

With a Buy rating, Mizuho initiated coverage on Confluent Inc CFLT. The price target seems to have been set at $28.00 for Confluent. For the fourth quarter, Confluent had an EPS of $0.09, compared to year-ago quarter EPS of $0.19. The current stock performance of Confluent shows a 52-week-high of $44.95 and a 52-week-low of $16.50. Moreover, at the end of the last trading period, the closing price was at $20.97.

See all analyst ratings initiations.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...